Company intelligence / Profile preview

Vivalto Family

Paris, France

Ownership: Private
Development stage: Other

Overview

Vivalto Partners is a French private equity firm specializing in healthcare investments, including healthcare services, pharmacy, consumer health, medical devices, and B2B services. It invests in companies such as Linnea SA (botanical ingredients manufacturer) and controls Vivalto Santé (a major private hospital group).

Industry: Investors

Partnerships

IK PartnersMACSFArkéa CapitalBNP Paribas DéveloppementGroupe Crédit AgricoleMubadalaBpifranceHayfin

Beyond the preview

Go deeper on Vivalto Family.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vivalto Family.

Explore the full profile